NASDAQ · Biotechnology

Vanda Pharmaceuticals Inc. (VNDA) Stock

$4.57 +0.88% NASDAQ: VNDA Healthcare

Valuation

MetricValue
Price$4.57
Market Cap$274.82M
P/E Ratio-1.00
P/B Ratio1.27
P/S Ratio1.29
EPS (TTM)$-3.74
52-Week High$9.94
52-Week Low$4.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-84.95%
ROA-66.64%
ROCE-74.73%
Gross Margin-69.91%
Operating Margin-69.91%
Net Margin-127.41%
Debt/Equity0.10
Current Ratio2.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$269.0M$254.0M$193.0M$199.0M$216.0M
Operating Profit$42.0M$6.0M$-14.0M$-41.0M$-151.0M
Net Profit$33.0M$6.0M$3.0M$-19.0M$-220.0M
EPS$0.58$0.11$0.04$-0.32$-3.74
Op Margin15.7%2.5%-7.2%-20.5%-70.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$594.0M$634.0M$648.0M$656.0M$489.0M
Total Liabilities$89.0M$107.0M$104.0M$118.0M$162.0M
Cash$52.0M$135.0M$136.0M$102.0M$85.0M
Borrowings$12.0M$11.0M$9.0M$12.0M$13.0M

Latest News

Vanda Reports Positive Opinion for Imsidolimab Orphan Drug Label MT Newswires · Jul 16, 2026 Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe PR Newswire · Jul 16, 2026 NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment PR Newswire · Jul 15, 2026 Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit PR Newswire · Jul 10, 2026 VNDA Stock Gains After-Hours As FDA Grants Rare Pediatric Disease Designation For Experimental Therapy Stocktwits · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$64.0M$32.0M$13.0M$-16.0M$-109.0M
Investing Cash Flow$-77.0M$49.0M$-12.0M$-18.0M$94.0M
Financing Cash Flow$0$0$0$0$-1.0M
Net Cash Flow$-9.0M$83.0M$1.0M$-34.0M$-17.0M
Free Cash Flow$64.0M$31.0M$12.0M$-16.0M$-110.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-1.47
FCF Yield-69.48%
Quick Ratio1.60
Interest Coverage0.00
Return 1Y10.74%
Return 3Y-16.64%
Return 5Y-69.77%

Ownership

Insiders Held6.65%
Institutions Held78.81%
Institutions Float Held84.43%
Institutional HolderSharesReport Date
Blackrock Inc.7,275,9882026-03-31
Renaissance Technologies, LLC3,759,5592026-03-31
State Street Corporation3,015,5622026-03-31
AIGH Capital Management LLC2,750,0002026-03-31
Vanguard Capital Management LLC2,481,4912026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHVAchieve Life Sciences, Inc. $7.41 +3.06% -4.67 $760.70M 0.00%
ALLOAllogene Therapeutics, Inc. $1.46 +4.29% -2.24 $503.93M 0.00%
ARCTArcturus Therapeutics Holdings Inc. $13.74 +6.76% -3.91 $390.53M 0.00%
AVIRAtea Pharmaceuticals, Inc. $5.15 -0.10% -2.47 $412.14M 0.00%
CAPRCapricor Therapeutics, Inc. $7.83 -2.25% -3.93 $450.31M 0.00%

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is led by CEO Mihael H. Polymeropoulos, employs 368 people, headquartered in US, publicly traded since 2006.

Vanda Pharmaceuticals Inc. (VNDA) stock trades at $4.57 with a market capitalization of $274.82M. The stock is valued at a price-to-earnings (P/E) ratio of -1.00, price-to-book of 1.27, price-to-sales of 1.29. Over the past 52 weeks the stock has ranged between $4.27 and $9.94, and currently trades 54.0% below its 52-week high.

On profitability, Vanda Pharmaceuticals Inc. generates a return on equity (ROE) of -84.95%, return on capital employed of -74.73%, an operating margin of -69.91%, a net profit margin of -127.41%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides